These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22406091)

  • 1. Conjugation of paclitaxel on adeno-associated virus (AAV) nanoparticles for co-delivery of genes and drugs.
    Wei F; McConnell KI; Yu TK; Suh J
    Eur J Pharm Sci; 2012 Jun; 46(3):167-72. PubMed ID: 22406091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed evolution of adeno-associated virus (AAV) as vector for muscle gene therapy.
    Yang L; Li J; Xiao X
    Methods Mol Biol; 2011; 709():127-39. PubMed ID: 21194025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
    Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
    Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
    Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and identification of recombinant adeno-associated virus vector harboring fusion gene NT4-Apoptin-HA2-TAT].
    Wang JS; Zhang MX; Liu DC; Duan XY; Zhou SN; Zhang GJ; Yang GX; Wang QY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):754-6. PubMed ID: 18687210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated superparamagnetic nanoparticle-mediated adeno-associated virus delivery for enhancing cellular transduction.
    Hwang JH; Lee S; Kim E; Kim JS; Lee CH; Ahn IS; Jang JH
    Int J Pharm; 2011 Dec; 421(2):397-404. PubMed ID: 22016032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene delivery using adeno-associated (AAV) vectors].
    Funato T
    Nihon Rinsho; 1998 Mar; 56(3):701-4. PubMed ID: 9549360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus vectors for gene therapy.
    Flotte TR; Carter BJ
    Gene Ther; 1995 Aug; 2(6):357-62. PubMed ID: 7584109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-based gene transfer.
    Büning H; Nicklin SA; Perabo L; Hallek M; Baker AH
    Curr Opin Mol Ther; 2003 Aug; 5(4):367-75. PubMed ID: 14513679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios.
    Aucoin MG; Perrier M; Kamen AA
    Biotechnol Bioeng; 2006 Dec; 95(6):1081-92. PubMed ID: 16952153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transposon-based mutagenesis generates diverse adeno-associated viral libraries with novel gene delivery properties.
    Koerber JT; Schaffer DV
    Methods Mol Biol; 2008; 434():161-70. PubMed ID: 18470644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.
    During MJ; Leone P
    Clin Neurosci; 1995-1996; 3(5):292-300. PubMed ID: 8914796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency.
    Hacker UT; Wingenfeld L; Kofler DM; Schuhmann NK; Lutz S; Herold T; King SB; Gerner FM; Perabo L; Rabinowitz J; McCarty DM; Samulski RJ; Hallek M; Büning H
    J Gene Med; 2005 Nov; 7(11):1429-38. PubMed ID: 15945124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
    Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
    Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetically enhanced adeno-associated viral vector delivery for human neural stem cell infection.
    Kim E; Oh JS; Ahn IS; Park KI; Jang JH
    Biomaterials; 2011 Nov; 32(33):8654-62. PubMed ID: 21840595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.